{
    "title": "Apellis Pharma's eye-disorder drug gets FDA approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11764929/Apellis-Pharmas-eye-disorder-drug-gets-FDA-approval.html",
    "date": "2023-02-17",
    "keywords": [
        "drug",
        "disorder",
        "treatment",
        "degeneration",
        "khushi",
        "mandowara",
        "eye",
        "company",
        "brand",
        "name",
        "syfovre",
        "disease",
        "ga",
        "growth",
        "blood",
        "loss",
        "specialty",
        "food",
        "administration",
        "blindness",
        "progression",
        "atrophy",
        "drugmaker",
        "market",
        "vial",
        "line",
        "factor",
        "formation",
        "cancer",
        "condition",
        "stage",
        "tissue",
        "vision",
        "empaveli",
        "hemoglobinuria",
        "apellis",
        "beginning",
        "march",
        "aditya",
        "samal",
        "bengaluru",
        "editing",
        "kuber",
        "chandra",
        "eluri"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}